Consumer Healthcare Market by Product (OTC Pharmaceuticals and Dietary Supplements); and Distribution Network (Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers, and Supermarkets or Hypermarkets) - Global Opportunities and Industry Forecasts, 2020-2027
|
A03171
|
Pages: NA
|
Jul 2020 |
7784 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Consumer Healthcare Market
Request Now !Consumer healthcare deals with products in wellness, oral health, nutrition, and skin health. Consumer healthcare products mainly constitute over-the-counter (OTC) drugs that include medicines, which are sold directly to a consumer without a prescription from a healthcare professional.
The major factors that contribute to the growth of the consumer healthcare market include high demand for self-medication, growing healthcare costs, increasing geriatric population who are more prone to contracting diseases, deterioration in mental health, and shift from medication prescription to OTC products. Moreover, the approval of wellness & preventive medicine and a rise in disposable income further boosts the market growth. However, stringent governmental regulations and the presence of counterfeit pharmaceuticals restrain the market. On the contrary, development & accelerated use of online sources, along with the increasing demand for branded products, private labels, and OTC generics will further provide numerous opportunities in the near future.
The global consumer healthcare market is segmented on the basis of products, distribution network, and region. Based on product, it is bifurcated into OTC pharmaceuticals and dietary supplements. On the basis of distribution network, the market is categorized into departmental stores, independent retailers, pharmacies or drugstores, specialist retailers, and supermarkets or hypermarkets. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in this market include Johnson & Johnson, Sanofi, Pfizer Inc., Abbott Laboratories, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Bayer AG, Amway, and BASF SE.
Key Benefits
- The study provides an in-depth analysis of the global consumer healthcare market with current trends and future estimations to elucidate imminent investment pockets.
- The report provides information about the current and upcoming trends in the global consumer healthcare market from 2016 to 2023, which helps determine prevailing opportunities.
- Comprehensive analysis of factors that drive and restrict the growth of the global consumer healthcare market has been provided.
- Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
- Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global consumer healthcare market.
Consumer Healthcare Market Key Segments:
By Product
- OTC Pharmaceuticals
- Dietary Supplements
By Distribution Network
- Departmental Stores
- Independent Retailers
- Pharmacies or Drugstores
- Specialist Retailers
- Supermarkets or Hypermarkets
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIE SUMMARY
2.1. CXO PERSPECTIE
CHAPTER 3 MARKET OERIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top inestment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Driers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 CONSUMER HEALTHCARE MARKET, BY PRODUCT
4.1. OERIEW
4.1.1. Market size and forecast
4.2. OTC PHARMACEUTICALS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. DIETARY SUPPLEMENTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION NETWORK
5.1. OERIEW
5.1.1. Market size and forecast
5.2. DEPARTMENTAL STORES
5.2.1. Market size and forecast
5.3. INDEPENDENT RETAILERS
5.3.1. Market size and forecast
5.4. PHARMACIES OR DRUGSTORES
5.4.1. Market size and forecast
5.5. SPECIALIST RETAILERS
5.5.1. Market size and forecast
5.6. SUPERMARKETS OR HYPERMARKETS
5.6.1. Market size and forecast
CHAPTER 6 CONSUMER HEALTHCARE MARKET, BY REGION
6.1. OERIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America consumer healthcare market by product
6.2.5. North America consumer healthcare market by distribution network
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe consumer healthcare market by product
6.3.5. Europe consumer healthcare market by distribution network
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific consumer healthcare market by product
6.4.5. Asia-Pacific consumer healthcare market by distribution network
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA consumer healthcare market by product
6.5.5. LAMEA consumer healthcare market by distribution network
CHAPTER 7 COMPANY PROFILES
7.1. JOHNSON & JOHNSON
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moes and deelopments
7.2. SANOFI
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moes and deelopments
7.3. PFIZER INC.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moes and deelopments
7.4. ABBOTT LABORATORIES
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moes and deelopments
7.5. GLAXOSMITHKLINE PLC
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moes and deelopments
7.6. BOEHRINGER INGELHEIM GMBH
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moes and deelopments
7.7. TEA PHARMACEUTICAL INDUSTRIES LTD.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moes and deelopments
7.8. BAYER AG
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moes and deelopments
7.9. AMWAY
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moes and deelopments
7.10. BASF SE
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moes and deelopments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Consumer Healthcare Market- Global
Opportunities and Industry Forecasts, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.